cobalt has been researched along with Anemia, Sickle Cell in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davies, KP; Fu, S; Melman, A; Tar, MT | 1 |
RATH, CE; STOHLMAN, F | 1 |
LEVY, IJ; WOLF, J | 1 |
GROSS, RT; KRISS, JP; SPAET, TH | 1 |
Bookchin, RM; Etzion, Z; Lew, VL; Tiffert, T | 1 |
Johnson, C; Kalra, VK; Shen, Y; Sultana, C | 1 |
6 other study(ies) available for cobalt and Anemia, Sickle Cell
Article | Year |
---|---|
Opiorphin is a master regulator of the hypoxic response in corporal smooth muscle cells.
Topics: Anemia, Sickle Cell; Animals; Cell Hypoxia; Cells, Cultured; Cobalt; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Myocytes, Smooth Muscle; Penis; Priapism; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2B; RNA Interference; RNA, Small Interfering; Salivary Proteins and Peptides; Up-Regulation | 2014 |
Cobaltous chloride therapy in sickle cell anemia.
Topics: Anemia; Anemia, Sickle Cell; Cobalt; Erythrocytes, Abnormal; Humans; Tracheophyta | 1953 |
Treatment of sickle cell anemia with cobalt chloride.
Topics: Anemia; Anemia, Sickle Cell; Cobalt; Erythrocytes, Abnormal; Humans; Tracheophyta | 1954 |
The hematopoletic and goltrogenic effects of cobaltous chloride in patients with sickle cell anemia.
Topics: Anemia; Anemia, Sickle Cell; Child; Cobalt; Goiter; Hemoglobins; Humans; Infant; Thyroid Gland | 1955 |
Effects of deoxygenation on active and passive Ca2+ transport and on the cytoplasmic Ca2+ levels of sickle cell anemia red cells.
Topics: Anemia, Sickle Cell; Biological Transport; Biological Transport, Active; Buffers; Calcimycin; Calcium; Calcium-Transporting ATPases; Cell Hypoxia; Cobalt; Cytoplasm; Erythrocytes; Humans; Hydrogen-Ion Concentration; Ions; Models, Chemical; Reticulocytes | 1993 |
Cobalt chloride-induced signaling in endothelium leading to the augmented adherence of sickle red blood cells and transendothelial migration of monocyte-like HL-60 cells is blocked by PAF-receptor antagonist.
Topics: Adult; Anemia, Sickle Cell; Base Sequence; Calcium-Calmodulin-Dependent Protein Kinases; Cell Adhesion; Cell Movement; Cells, Cultured; Cobalt; E-Selectin; Endothelium, Vascular; Enzyme Inhibitors; Erythrocytes, Abnormal; Flavonoids; HL-60 Cells; Humans; Hypoxia; Indoles; Intercellular Adhesion Molecule-1; Maleimides; Marine Toxins; Mitogen-Activated Protein Kinase 1; Molecular Sequence Data; NF-kappa B; Oxazoles; Phospholipid Ethers; Phosphoprotein Phosphatases; Phosphorylation; Platelet Endothelial Cell Adhesion Molecule-1; Platelet Membrane Glycoproteins; Protein Processing, Post-Translational; Receptors, Cell Surface; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Transcription Factor AP-1; Umbilical Veins; Vascular Cell Adhesion Molecule-1 | 1999 |